We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In E I du Pont Nemours & Co.’s SPC Application (2009 EWHC 1112 (Ch)) the High Court considered an appeal from a decision of the UK Intellectual Property Office to refuse a six month extension of a Supplementary Protection Certificate covering Cozaar (Losartan, an antihypertensive) under the Paediatric Regulation 19012006
On 10 May 2009, the High Court handed down its judgment in Generics (UK) Limited v Synaptech Inc, holding that the "first authorisation to place the product on the market in the Community" in Article 13 of the EC Council Regulation 176892 (the "Regulation") referred only to marketing authorisations granted in accordance with Directive 6565EEC
